In-vitro Diagnostics Enzymes Market Size, Share & Trends Analysis Report By Enzyme Type (Polymerase & Transcriptase, Proteases), By Disease Type, By Technology Type, By End-use, By Region, And Segment Forecasts, 2020 - 2027
- Report ID: GVR-4-68039-246-6
- Number of Pages: 199
- Format: Electronic (PDF)
- Historical Range: 2016 - 2018
- Industry: Healthcare
Market Segmentation
- IVD Enzymes Type Outlook (Revenue, USD Million, 2016 - 2027)
- Proteases
- By Disease Type
- Infectious disease
- Diabetes
- Oncology
- Cardiology
- Nephrology
- Autoimmune diseases
- Others
- By Technology Use
- Histology Assays
- Molecular Diagnostics
- PCR Assays
- NGS Assays
- Others
- Clinical Chemistry
- By Physical Form
- Powder
- Liquid
- By Type
- Natural
- Recombinant
- By End-use
- Pharma & Biotech
- Hospital & Diagnostic Labs
- CROs
- Academic Labs
- By Disease Type
- Polymerase & Transcriptase
- Ribonuclease
- Others
- Proteases
- IVD Enzymes Therapeutic Area Outlook (Revenue, USD Million, 2016 - 2027)
- Infectious disease
- COVID-19 Testing
- Hepatitis
- HIV
- Others
- Diabetes
- Oncology
- Cardiology
- Nephrology
- Autoimmune diseases
- Others
- Infectious disease
- IVD Enzymes Technology Type Outlook (Revenue, USD Million, 2016 - 2027)
- Histology Assays
- Molecular Diagnostics
- PCR Assays
- NGS Assays
- Others
- Clinical Chemistry
- IVD Enzymes End-use Outlook (Revenue, USD Million, 2016 - 2027)
- Pharma & Biotech
- Hospital & Diagnostic Labs
- Contract Research Organizations (CROs)
- Academic Labs
- IVD Enzymes Regional Outlook (Revenue, USD Million, 2016 - 2027)
- North America
- North America IVD Enzymes Market, By Enzyme Type
- Proteases
- By Disease Type
- Infectious disease
- Diabetes
- Oncology
- Cardiology
- Nephrology
- Autoimmune diseases
- Others
- By Technology Use
- Histology Assays
- Molecular Diagnostics
- PCR Assays
- NGS Assays
- Others
- Clinical Chemistry
- By Physical Form
- Powder
- Liquid
- By Type
- Natural
- Recombinant
- By End-use
- Pharma & Biotech
- Hospital & Diagnostic Labs
- CROs
- Academic Labs
- By Disease Type
- Polymerase & Transcriptase
- Ribonuclease
- Others
- Proteases
- North America IVD Enzymes Market, By Therapeutic Area
- Infectious disease
- COVID-19 Testing
- Hepatitis
- HIV
- Others
- Diabetes
- Oncology
- Cardiology
- Nephrology
- Autoimmune diseases
- Others
- Infectious disease
- North America IVD Enzymes Market, By Technology Type
- Histology Assays
- Molecular Diagnostics
- PCR Assays
- NGS Assays
- Others
- Clinical Chemistry
- North America IVD Enzymes Market, By End Use
- Pharma & Biotech
- Hospital & Diagnostic Labs
- Contract Research Organizations (CROs)
- Academic Labs
- U.S.
- U.S. IVD Enzymes Market, By Enzyme Type
- Proteases
- By Disease Type
- Infectious disease
- Diabetes
- Oncology
- Cardiology
- Nephrology
- Autoimmune diseases
- Others
- By Technology Use
- Histology Assays
- Molecular Diagnostics
- PCR Assays
- NGS Assays
- Others
- Clinical Chemistry
- By Physical Form
- Powder
- Liquid
- By Type
- Natural
- Recombinant
- By End-use
- Pharma & Biotech
- Hospital & Diagnostic Labs
- CROs
- Academic Labs
- By Disease Type
- Polymerase & Transcriptase
- Ribonuclease
- Others
- Proteases
- U.S. IVD Enzymes Market, By Therapeutic Area
- Infectious disease
- COVID-19 Testing
- Hepatitis
- HIV
- Others
- Diabetes
- Oncology
- Cardiology
- Nephrology
- Autoimmune diseases
- Others
- Infectious disease
- U.S. IVD Enzymes Market, By Technology Type
- Histology Assays
- Molecular Diagnostics
- PCR Assays
- NGS Assays
- Others
- Clinical Chemistry
- U.S. IVD Enzymes Market, By End Use
- Pharma & Biotech
- Hospital & Diagnostic Labs
- Contract Research Organizations (CROs)
- Academic Labs
- U.S. IVD Enzymes Market, By Enzyme Type
- Canada
- Canada IVD Enzymes Market, By Enzyme Type
- Proteases
- By Disease Type
- Infectious disease
- Diabetes
- Oncology
- Cardiology
- Nephrology
- Autoimmune diseases
- Others
- By Technology Use
- Histology Assays
- Molecular Diagnostics
- PCR Assays
- NGS Assays
- Others
- Clinical Chemistry
- By Physical Form
- Powder
- Liquid
- By Type
- Natural
- Recombinant
- By End-use
- Pharma & Biotech
- Hospital & Diagnostic Labs
- CROs
- Academic Labs
- By Disease Type
- Polymerase & Transcriptase
- Ribonuclease
- Others
- Proteases
- Canada IVD Enzymes Market, By Therapeutic Area
- Infectious disease
- COVID-19 Testing
- Hepatitis
- HIV
- Others
- Diabetes
- Oncology
- Cardiology
- Nephrology
- Autoimmune diseases
- Others
- Infectious disease
- Canada IVD Enzymes Market, By Technology Type
- Histology Assays
- Molecular Diagnostics
- PCR Assays
- NGS Assays
- Others
- Clinical Chemistry
- Canada IVD Enzymes Market, By End Use
- Pharma & Biotech
- Hospital & Diagnostic Labs
- Contract Research Organizations (CROs)
- Academic Labs
- Canada IVD Enzymes Market, By Enzyme Type
- North America IVD Enzymes Market, By Enzyme Type
- Europe
- Europe IVD Enzymes Market, By Enzyme Type
- Proteases
- By Disease Type
- Infectious disease
- Diabetes
- Oncology
- Cardiology
- Nephrology
- Autoimmune diseases
- Others
- By Technology Use
- Histology Assays
- Molecular Diagnostics
- PCR Assays
- NGS Assays
- Others
- Clinical Chemistry
- By Physical Form
- Powder
- Liquid
- By Type
- Natural
- Recombinant
- By End-use
- Pharma & Biotech
- Hospital & Diagnostic Labs
- CROs
- Academic Labs
- By Disease Type
- Polymerase & Transcriptase
- Ribonuclease
- Others
- Proteases
- Europe IVD Enzymes Market, By Therapeutic Area
- Infectious disease
- COVID-19 Testing
- Hepatitis
- HIV
- Others
- Diabetes
- Oncology
- Cardiology
- Nephrology
- Autoimmune diseases
- Others
- Infectious disease
- Europe IVD Enzymes Market, By Technology Type
- Histology Assays
- Molecular Diagnostics
- PCR Assays
- NGS Assays
- Others
- Clinical Chemistry
- Europe IVD Enzymes Market, By End Use
- Pharma & Biotech
- Hospital & Diagnostic Labs
- Contract Research Organizations (CROs)
- Academic Labs
- Germany
- Germany IVD Enzymes Market, By Enzyme Type
- Proteases
- By Disease Type
- Infectious disease
- Diabetes
- Oncology
- Cardiology
- Nephrology
- Autoimmune diseases
- Others
- By Technology Use
- Histology Assays
- Molecular Diagnostics
- PCR Assays
- NGS Assays
- Others
- Clinical Chemistry
- By Physical Form
- Powder
- Liquid
- By Type
- Natural
- Recombinant
- By End-use
- Pharma & Biotech
- Hospital & Diagnostic Labs
- CROs
- Academic Labs
- By Disease Type
- Polymerase & Transcriptase
- Ribonuclease
- Others
- Proteases
- Germany IVD Enzymes Market, By Therapeutic Area
- Infectious disease
- COVID-19 Testing
- Hepatitis
- HIV
- Others
- Diabetes
- Oncology
- Cardiology
- Nephrology
- Autoimmune diseases
- Others
- Infectious disease
- Germany IVD Enzymes Market, By Technology Type
- Histology Assays
- Molecular Diagnostics
- PCR Assays
- NGS Assays
- Others
- Clinical Chemistry
- Germany IVD Enzymes Market, By End Use
- Pharma & Biotech
- Hospital & Diagnostic Labs
- Contract Research Organizations (CROs)
- Academic Labs
- Germany IVD Enzymes Market, By Enzyme Type
- France
- France IVD Enzymes Market, By Enzyme Type
- Proteases
- By Disease Type
- Infectious disease
- Diabetes
- Oncology
- Cardiology
- Nephrology
- Autoimmune diseases
- Others
- By Technology Use
- Histology Assays
- Molecular Diagnostics
- PCR Assays
- NGS Assays
- Others
- Clinical Chemistry
- By Physical Form
- Powder
- Liquid
- By Type
- Natural
- Recombinant
- By End-use
- Pharma & Biotech
- Hospital & Diagnostic Labs
- CROs
- Academic Labs
- By Disease Type
- Polymerase & Transcriptase
- Ribonuclease
- Others
- Proteases
- France IVD Enzymes Market, By Therapeutic Area
- Infectious disease
- COVID-19 Testing
- Hepatitis
- HIV
- Others
- Diabetes
- Oncology
- Cardiology
- Nephrology
- Autoimmune diseases
- Others
- Infectious disease
- France IVD Enzymes Market, By Technology Type
- Histology Assays
- Molecular Diagnostics
- PCR Assays
- NGS Assays
- Others
- Clinical Chemistry
- France IVD Enzymes Market, By End Use
- Pharma & Biotech
- Hospital & Diagnostic Labs
- Contract Research Organizations (CROs)
- Academic Labs
- France IVD Enzymes Market, By Enzyme Type
- U.K.
- U.K. IVD Enzymes Market, By Enzyme Type
- Proteases
- By Disease Type
- Infectious disease
- Diabetes
- Oncology
- Cardiology
- Nephrology
- Autoimmune diseases
- Others
- By Technology Use
- Histology Assays
- Molecular Diagnostics
- PCR Assays
- NGS Assays
- Others
- Clinical Chemistry
- By Physical Form
- Powder
- Liquid
- By Type
- Natural
- Recombinant
- By End-use
- Pharma & Biotech
- Hospital & Diagnostic Labs
- CROs
- Academic Labs
- By Disease Type
- Polymerase & Transcriptase
- Ribonuclease
- Others
- Proteases
- U.K. IVD Enzymes Market, By Therapeutic Area
- Infectious disease
- COVID-19 Testing
- Hepatitis
- HIV
- Others
- Diabetes
- Oncology
- Cardiology
- Nephrology
- Autoimmune diseases
- Others
- Infectious disease
- U.K. IVD Enzymes Market, By Technology Type
- Histology Assays
- Molecular Diagnostics
- PCR Assays
- NGS Assays
- Others
- Clinical Chemistry
- U.K. IVD Enzymes Market, By End Use
- Pharma & Biotech
- Hospital & Diagnostic Labs
- Contract Research Organizations (CROs)
- Academic Labs
- U.K. IVD Enzymes Market, By Enzyme Type
- Italy
- Italy IVD Enzymes Market, By Enzyme Type
- Proteases
- By Disease Type
- Infectious disease
- Diabetes
- Oncology
- Cardiology
- Nephrology
- Autoimmune diseases
- Others
- By Technology Use
- Histology Assays
- Molecular Diagnostics
- PCR Assays
- NGS Assays
- Others
- Clinical Chemistry
- By Physical Form
- Powder
- Liquid
- By Type
- Natural
- Recombinant
- By End-use
- Pharma & Biotech
- Hospital & Diagnostic Labs
- CROs
- Academic Labs
- By Disease Type
- Polymerase & Transcriptase
- Ribonuclease
- Others
- Proteases
- Italy IVD Enzymes Market, By Therapeutic Area
- Infectious disease
- COVID-19 Testing
- Hepatitis
- HIV
- Others
- Diabetes
- Oncology
- Cardiology
- Nephrology
- Autoimmune diseases
- Others
- Infectious disease
- Italy IVD Enzymes Market, By Technology Type
- Histology Assays
- Molecular Diagnostics
- PCR Assays
- NGS Assays
- Others
- Clinical Chemistry
- Italy IVD Enzymes Market, By End Use
- Pharma & Biotech
- Hospital & Diagnostic Labs
- Contract Research Organizations (CROs)
- Academic Labs
- Italy IVD Enzymes Market, By Enzyme Type
- Spain
- Spain IVD Enzymes Market, By Enzyme Type
- Proteases
- By Disease Type
- Infectious disease
- Diabetes
- Oncology
- Cardiology
- Nephrology
- Autoimmune diseases
- Others
- By Technology Use
- Histology Assays
- Molecular Diagnostics
- PCR Assays
- NGS Assays
- Others
- Clinical Chemistry
- By Physical Form
- Powder
- Liquid
- By Type
- Natural
- Recombinant
- By End-use
- Pharma & Biotech
- Hospital & Diagnostic Labs
- CROs
- Academic Labs
- By Disease Type
- Polymerase & Transcriptase
- Ribonuclease
- Others
- Proteases
- Spain IVD Enzymes Market, By Therapeutic Area
- Infectious disease
- COVID-19 Testing
- Hepatitis
- HIV
- Others
- Diabetes
- Oncology
- Cardiology
- Nephrology
- Autoimmune diseases
- Others
- Infectious disease
- Spain IVD Enzymes Market, By Technology Type
- Histology Assays
- Molecular Diagnostics
- PCR Assays
- NGS Assays
- Others
- Clinical Chemistry
- Spain IVD Enzymes Market, By End Use
- Pharma & Biotech
- Hospital & Diagnostic Labs
- Contract Research Organizations (CROs)
- Academic Labs
- Spain IVD Enzymes Market, By Enzyme Type
- Europe IVD Enzymes Market, By Enzyme Type
- Asia Pacific
- Asia Pacific IVD Enzymes Market, By Enzyme Type
- Proteases
- By Disease Type
- Infectious disease
- Diabetes
- Oncology
- Cardiology
- Nephrology
- Autoimmune diseases
- Others
- By Technology Use
- Histology Assays
- Molecular Diagnostics
- PCR Assays
- NGS Assays
- Others
- Clinical Chemistry
- By Physical Form
- Powder
- Liquid
- By Type
- Natural
- Recombinant
- By End-use
- Pharma & Biotech
- Hospital & Diagnostic Labs
- CROs
- Academic Labs
- By Disease Type
- Polymerase & Transcriptase
- Ribonuclease
- Others
- Proteases
- Asia Pacific IVD Enzymes Market, By Therapeutic Area
- Infectious disease
- COVID-19 Testing
- Hepatitis
- HIV
- Others
- Diabetes
- Oncology
- Cardiology
- Nephrology
- Autoimmune diseases
- Others
- Infectious disease
- Asia Pacific IVD Enzymes Market, By Technology Type
- Histology Assays
- Molecular Diagnostics
- PCR Assays
- NGS Assays
- Others
- Clinical Chemistry
- Asia Pacific IVD Enzymes Market, By End Use
- Pharma & Biotech
- Hospital & Diagnostic Labs
- Contract Research Organizations (CROs)
- Academic Labs
- Japan
- Japan IVD Enzymes Market, By Enzyme Type
- Proteases
- By Disease Type
- Infectious disease
- Diabetes
- Oncology
- Cardiology
- Nephrology
- Autoimmune diseases
- Others
- By Technology Use
- Histology Assays
- Molecular Diagnostics
- PCR Assays
- NGS Assays
- Others
- Clinical Chemistry
- By Physical Form
- Powder
- Liquid
- By Type
- Natural
- Recombinant
- By End-use
- Pharma & Biotech
- Hospital & Diagnostic Labs
- CROs
- Academic Labs
- By Disease Type
- Polymerase & Transcriptase
- Ribonuclease
- Others
- Proteases
- Japan IVD Enzymes Market, By Therapeutic Area
- Infectious disease
- COVID-19 Testing
- Hepatitis
- HIV
- Others
- Diabetes
- Oncology
- Cardiology
- Nephrology
- Autoimmune diseases
- Others
- Infectious disease
- Japan IVD Enzymes Market, By Technology Type
- Histology Assays
- Molecular Diagnostics
- PCR Assays
- NGS Assays
- Others
- Clinical Chemistry
- Japan IVD Enzymes Market, By End Use
- Pharma & Biotech
- Hospital & Diagnostic Labs
- Contract Research Organizations (CROs)
- Academic Labs
- Japan IVD Enzymes Market, By Enzyme Type
- China
- China IVD Enzymes Market, By Enzyme Type
- Proteases
- By Disease Type
- Infectious disease
- Diabetes
- Oncology
- Cardiology
- Nephrology
- Autoimmune diseases
- Others
- By Technology Use
- Histology Assays
- Molecular Diagnostics
- PCR Assays
- NGS Assays
- Others
- Clinical Chemistry
- By Physical Form
- Powder
- Liquid
- By Type
- Natural
- Recombinant
- By End-use
- Pharma & Biotech
- Hospital & Diagnostic Labs
- CROs
- Academic Labs
- By Disease Type
- Polymerase & Transcriptase
- Ribonuclease
- Others
- Proteases
- China IVD Enzymes Market, By Therapeutic Area
- Infectious disease
- COVID-19 Testing
- Hepatitis
- HIV
- Others
- Diabetes
- Oncology
- Cardiology
- Nephrology
- Autoimmune diseases
- Others
- Infectious disease
- China IVD Enzymes Market, By Technology Type
- Histology Assays
- Molecular Diagnostics
- PCR Assays
- NGS Assays
- Others
- Clinical Chemistry
- China IVD Enzymes Market, By End Use
- Pharma & Biotech
- Hospital & Diagnostic Labs
- Contract Research Organizations (CROs)
- Academic Labs
- China IVD Enzymes Market, By Enzyme Type
- India
- India IVD Enzymes Market, By Enzyme Type
- Proteases
- By Disease Type
- Infectious disease
- Diabetes
- Oncology
- Cardiology
- Nephrology
- Autoimmune diseases
- Others
- By Technology Use
- Histology Assays
- Molecular Diagnostics
- PCR Assays
- NGS Assays
- Others
- Clinical Chemistry
- By Physical Form
- Powder
- Liquid
- By Type
- Natural
- Recombinant
- By End-use
- Pharma & Biotech
- Hospital & Diagnostic Labs
- CROs
- Academic Labs
- By Disease Type
- Polymerase & Transcriptase
- Ribonuclease
- Others
- Proteases
- India IVD Enzymes Market, By Therapeutic Area
- Infectious disease
- COVID-19 Testing
- Hepatitis
- HIV
- Others
- Diabetes
- Oncology
- Cardiology
- Nephrology
- Autoimmune diseases
- Others
- Infectious disease
- India IVD Enzymes Market, By Technology Type
- Histology Assays
- Molecular Diagnostics
- PCR Assays
- NGS Assays
- Others
- Clinical Chemistry
- India IVD Enzymes Market, By End Use
- Pharma & Biotech
- Hospital & Diagnostic Labs
- Contract Research Organizations (CROs)
- Academic Labs
- India IVD Enzymes Market, By Enzyme Type
- Asia Pacific IVD Enzymes Market, By Enzyme Type
- Latin America
- Latin America IVD Enzymes Market, By Enzyme Type
- Proteases
- By Disease Type
- Infectious disease
- Diabetes
- Oncology
- Cardiology
- Nephrology
- Autoimmune diseases
- Others
- By Technology Use
- Histology Assays
- Molecular Diagnostics
- PCR Assays
- NGS Assays
- Others
- Clinical Chemistry
- By Physical Form
- Powder
- Liquid
- By Type
- Natural
- Recombinant
- By End-use
- Pharma & Biotech
- Hospital & Diagnostic Labs
- CROs
- Academic Labs
- By Disease Type
- Polymerase & Transcriptase
- Ribonuclease
- Others
- Proteases
- Latin America IVD Enzymes Market, By Therapeutic Area
- Infectious disease
- COVID-19 Testing
- Hepatitis
- HIV
- Others
- Diabetes
- Oncology
- Cardiology
- Nephrology
- Autoimmune diseases
- Others
- Infectious disease
- Latin America IVD Enzymes Market, By Technology Type
- Histology Assays
- Molecular Diagnostics
- PCR Assays
- NGS Assays
- Others
- Clinical Chemistry
- Latin America IVD Enzymes Market, By End Use
- Pharma & Biotech
- Hospital & Diagnostic Labs
- Contract Research Organizations (CROs)
- Academic Labs
- Brazil
- Brazil IVD Enzymes Market, By Enzyme Type
- Proteases
- By Disease Type
- Infectious disease
- Diabetes
- Oncology
- Cardiology
- Nephrology
- Autoimmune diseases
- Others
- By Technology Use
- Histology Assays
- Molecular Diagnostics
- PCR Assays
- NGS Assays
- Others
- Clinical Chemistry
- By Physical Form
- Powder
- Liquid
- By Type
- Natural
- Recombinant
- By End-use
- Pharma & Biotech
- Hospital & Diagnostic Labs
- CROs
- Academic Labs
- By Disease Type
- Polymerase & Transcriptase
- Ribonuclease
- Others
- Proteases
- Brazil IVD Enzymes Market, By Therapeutic Area
- Infectious disease
- COVID-19 Testing
- Hepatitis
- HIV
- Others
- Diabetes
- Oncology
- Cardiology
- Nephrology
- Autoimmune diseases
- Others
- Infectious disease
- Brazil IVD Enzymes Market, By Technology Type
- Histology Assays
- Molecular Diagnostics
- PCR Assays
- NGS Assays
- Others
- Clinical Chemistry
- Brazil IVD Enzymes Market, By End Use
- Pharma & Biotech
- Hospital & Diagnostic Labs
- Contract Research Organizations (CROs)
- Academic Labs
- Brazil IVD Enzymes Market, By Enzyme Type
- Mexico
- Mexico IVD Enzymes Market, By Enzyme Type
- Proteases
- By Disease Type
- Infectious disease
- Diabetes
- Oncology
- Cardiology
- Nephrology
- Autoimmune diseases
- Others
- By Technology Use
- Histology Assays
- Molecular Diagnostics
- PCR Assays
- NGS Assays
- Others
- Clinical Chemistry
- By Physical Form
- Powder
- Liquid
- By Type
- Natural
- Recombinant
- By End-use
- Pharma & Biotech
- Hospital & Diagnostic Labs
- CROs
- Academic Labs
- By Disease Type
- Polymerase & Transcriptase
- Ribonuclease
- Others
- Proteases
- Mexico IVD Enzymes Market, By Therapeutic Area
- Infectious disease
- COVID-19 Testing
- Hepatitis
- HIV
- Others
- Diabetes
- Oncology
- Cardiology
- Nephrology
- Autoimmune diseases
- Others
- Infectious disease
- Mexico IVD Enzymes Market, By Technology Type
- Histology Assays
- Molecular Diagnostics
- PCR Assays
- NGS Assays
- Others
- Clinical Chemistry
- Mexico IVD Enzymes Market, By End Use
- Pharma & Biotech
- Hospital & Diagnostic Labs
- Contract Research Organizations (CROs)
- Academic Labs
- Mexico IVD Enzymes Market, By Enzyme Type
- Latin America IVD Enzymes Market, By Enzyme Type
- Middle East and Africa (MEA)
- Middle East and Africa IVD Enzymes Market, By Enzyme Type
- Proteases
- By Disease Type
- Infectious disease
- Diabetes
- Oncology
- Cardiology
- Nephrology
- Autoimmune diseases
- Others
- By Technology Use
- Histology Assays
- Molecular Diagnostics
- PCR Assays
- NGS Assays
- Others
- Clinical Chemistry
- By Physical Form
- Powder
- Liquid
- By Type
- Natural
- Recombinant
- By End-use
- Pharma & Biotech
- Hospital & Diagnostic Labs
- CROs
- Academic Labs
- By Disease Type
- Polymerase & Transcriptase
- Ribonuclease
- Others
- Proteases
- Middle East and Africa IVD Enzymes Market, By Therapeutic Area
- Infectious disease
- COVID-19 Testing
- Hepatitis
- HIV
- Others
- Diabetes
- Oncology
- Cardiology
- Nephrology
- Autoimmune diseases
- Others
- Infectious disease
- Middle East and Africa IVD Enzymes Market, By Technology Type
- Histology Assays
- Molecular Diagnostics
- PCR Assays
- NGS Assays
- Others
- Clinical Chemistry
- Middle East and Africa IVD Enzymes Market, By End Use
- Pharma & Biotech
- Hospital & Diagnostic Labs
- Contract Research Organizations (CROs)
- Academic Labs
- South Africa
- South Africa IVD Enzymes Market, By Enzyme Type
- Proteases
- By Disease Type
- Infectious disease
- Diabetes
- Oncology
- Cardiology
- Nephrology
- Autoimmune diseases
- Others
- By Technology Use
- Histology Assays
- Molecular Diagnostics
- PCR Assays
- NGS Assays
- Others
- Clinical Chemistry
- By Physical Form
- Powder
- Liquid
- By Type
- Natural
- Recombinant
- By End-use
- Pharma & Biotech
- Hospital & Diagnostic Labs
- CROs
- Academic Labs
- By Disease Type
- Polymerase & Transcriptase
- Ribonuclease
- Others
- Proteases
- South Africa IVD Enzymes Market, By Therapeutic Area
- Infectious disease
- COVID-19 Testing
- Hepatitis
- HIV
- Others
- Diabetes
- Oncology
- Cardiology
- Nephrology
- Autoimmune diseases
- Others
- Infectious disease
- South Africa IVD Enzymes Market, By Technology Type
- Histology Assays
- Molecular Diagnostics
- PCR Assays
- NGS Assays
- Others
- Clinical Chemistry
- South Africa IVD Enzymes Market, By End Use
- Pharma & Biotech
- Hospital & Diagnostic Labs
- Contract Research Organizations (CROs)
- Academic Labs
- South Africa IVD Enzymes Market, By Enzyme Type
- Middle East and Africa IVD Enzymes Market, By Enzyme Type
- North America
Report content
Qualitative Analysis
- Industry overview
- Industry trends
- Market drivers and restraints
- Market size
- Growth prospects
- Porter’s analysis
- PESTEL analysis
- Key market opportunities prioritized
- Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments
Quantitative Analysis
- Market size, estimates, and forecast from 2016 to 2027
- Market estimates and forecast for product segments up to 2027
- Regional market size and forecast for product segments up to 2027
- Market estimates and forecast for application segments up to 2027
- Regional market size and forecast for application segments up to 2027
- Company financial performance
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member
Leading SME award by D&B
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
